ATLAS / Macro Radar / Reporting / CHRS

Coherus Oncology, Inc. (CHRS) reporting calendar

Coherus Oncology, Inc. files periodic reports with the SEC as CHRS on Nasdaq. Atlas tracks 47 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
21 Jul 2026 – 28 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
11 May 2026
Reports on record
47

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 40 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open CHRS market profile Latest filing on SEC EDGAR ↗ Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202611 May 202641 days0001104659-26-058703
10-K31 Dec 20259 Mar 202668 days0001104659-26-025308
10-Q30 Sep 20256 Nov 202537 days0001104659-25-107852
10-Q30 Jun 20257 Aug 202538 days0001558370-25-010803
10-Q31 Mar 202512 May 202542 days0001558370-25-007418
10-K31 Dec 202417 Mar 202576 days0001558370-25-003126
10-Q30 Sep 20246 Nov 202437 days0001558370-24-014648
10-Q30 Jun 20248 Aug 202439 days0001558370-24-011629
10-Q31 Mar 20249 May 202439 days0001558370-24-007641
10-K31 Dec 202315 Mar 202475 days0001558370-24-003436
10-Q30 Sep 20236 Nov 202337 days0001558370-23-017779
10-Q30 Jun 20232 Aug 202333 days0001558370-23-012915
10-Q31 Mar 20238 May 202338 days0001558370-23-008529
10-K31 Dec 20226 Mar 202365 days0001558370-23-002917
10-Q30 Sep 20228 Nov 202239 days0001558370-22-016850
10-Q30 Jun 20224 Aug 202235 days0001558370-22-012251
10-Q31 Mar 20225 May 202235 days0001558370-22-007420
10-K31 Dec 202123 Feb 202254 days0001558370-22-001764
10-Q30 Sep 20218 Nov 202139 days0001558370-21-015033
10-Q30 Jun 20215 Aug 202136 days0001558370-21-010563
10-Q31 Mar 20216 May 202136 days0001558370-21-006257
10-K31 Dec 202025 Feb 202156 days0001558370-21-001829
10-Q30 Sep 20205 Nov 202036 days0001558370-20-012864
10-Q30 Jun 20206 Aug 202037 days0001558370-20-009657
10-Q31 Mar 20207 May 202037 days0001558370-20-005749
10-K31 Dec 201927 Feb 202058 days0001564590-20-007416
10-Q30 Sep 20198 Nov 201939 days0001564590-19-042255
10-Q30 Jun 20195 Aug 201936 days0001564590-19-028841
10-Q31 Mar 20199 May 201939 days0001564590-19-018007
10-K31 Dec 201828 Feb 201959 days0001564590-19-005470
10-Q30 Sep 20188 Nov 201839 days0001564590-18-028562
10-Q30 Jun 20188 Aug 201839 days0001564590-18-020492
10-Q31 Mar 201810 May 201840 days0001564590-18-012976
10-K31 Dec 20178 Mar 201867 days0001564590-18-004947
10-Q30 Sep 20176 Nov 201737 days0001564590-17-021844
10-Q30 Jun 20177 Aug 201738 days0001564590-17-016017
10-Q31 Mar 20178 May 201738 days0001564590-17-009394
10-K31 Dec 201614 Mar 201773 days0001564590-17-004176
10-Q30 Sep 20169 Nov 201640 days0001564590-16-028634
10-Q30 Jun 20169 Aug 201640 days0001564590-16-023684

Source: SEC EDGAR company submissions for CIK 0001512762. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.